In both the training and validation sets, the sex distribution, histories of chronic conditions (e.g., malignancy, diabetes, and hypertension), and laboratory research indices did not vary substantially between the high and low Ki-67 expression groups. This evidence concerns the gene MKI67 and diabetes mellitus.